Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator

AIMS: Fingolimod is a sphingosine‐1‐phosphate (S1P) receptor modulator approved for the treatment of the relapsing form of multiple sclerosis (MS). It prevents the egress of lymphocyte subpopulations from lymphoid tissues into the circulation. Here, we explored the broad effects of fingolimod on gen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Angerer, Ines C., Hecker, Michael, Koczan, Dirk, Roch, Luisa, Friess, Jörg, Rüge, Annelen, Fitzner, Brit, Boxberger, Nina, Schröder, Ina, Flechtner, Kristin, Thiesen, Hans‐Jürgen, Winkelmann, Alexander, Meister, Stefanie, Zettl, Uwe K.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490155/
https://ncbi.nlm.nih.gov/pubmed/29314605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12793
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados